Abstract
An animal model with liver cancer recurrence was induced by resecting colonic VX2 cancer lesions in 57 rabbits, and the effects of doxorubicin (ADR) on the recurrence were examined. Animals were divided into a control group and three chemotherapeutic groups: a portal injection group, to which ADR was injected into the portal vein after resection of the primary lesions; a peripheral injection group, to which ADR was injected into a peripheral vein after resection; and a preoperative injection group, to which an ADR dose of 0.5 mg/kg was peripherally injected 0, 1, and 2 days prior to resection followed by a portal injection of ADR 0.5 mg/kg after resection. The rate of liver recurrence was 100% in the control group, whereas it was 0% and 60% in the portal ADR 1.0 and 0.5 mg/kg injection groups, and 60% and 100% in the peripheral ADR 1.0 and 0.5 mg/kg injection groups. In the preoperative group, the rate was 0%, 100%, and 67% in the animals injected 2, 1, and 0 days prior to resection, respectively. These results suggest that portal injection or appropriate combinations of preoperative peripheral and portal injections of ADR are more effective than peripheral or portal injection alone in the suppression of liver recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cohen AM, Shank B, Friedmann MA (1989) Colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology, 3rd edn. Lippincott, Philadelphia, pp 859–952
Filder IJ, Hart LR (1982) Principle of cancer biology: Biology of cancer metastasis. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology. Lippincott, Philadelphia, pp 80–92
Schirrmacher V (1985) Cancer metastasis: Experimental approaches, theoretical concepts and impacts for treatment strategies. Adv Cancer Res 43:1–64
Liotta LA, Stetler-Stevenson WG (1989) Principle of molecular cell biology of cancer: Cancer metastasis. DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology, 3rd edn. Lippincott, Philadelphia, pp 98–115
Wanebo HJ, Semoglou C, Attiyeh F, Fadi A, Maus SJ Jr (1978) Surgical management of patients with primary operable colorectal cancer and synchronous liver metastasis. Am J Surg 135:81–85
Iwatsuki S, Esquivel CO, Goldson RD, Starzl TE (1986) Liver resection for metastatic colorectal cancer. Surgery 100:804–810
DeVita VT Jr (1989) Principles for chemotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology, 3rd edn. Lippincott, Philadelphia, pp 276–300
Rous P, Kidd J, Smith WE (1952) Experiment on the cause of rabbit carcinoma derived from virus-induced papillomas. II. Loss by the VX2 carcinoma of the power to immunize host against the papilloma virus. J Exp Med 96:159–174
Tabuchi Y, Nakae S, Nakamura T, Saitoh Y (1989) Developmental process of liver metastases induced by intraportal and gastrointestinal implantation of VX2 cancer. Bull Allied Med Sci (Kobe) 5:1–12
Tabuchi Y, Nakamura T, Saitoh Y (1991) Liver metastases induced by implantation of VX2 cancer into the gastrointestine. J Surg Res 50:216–222
Tabuchi Y, Nakamura T, Imanishi K, Saitoh Y (1988) Usefulness of resorcin-fuchsin (Weigert) HE stain for various cancer specimens. Bull Allied Med Sci (Kobe) 4:89–93
Grossi CE, Nealson TF, Rousselot LM (1972) Adjuvant chemotherapy in resectable cancer of the colon and rectum. Surg Clin North Am 52:925–933
Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C (1985) A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 75:359–363
Kodaira S, Kikuchi K, Inokuchi K, Komi N, Hattori T, Taguchi T, Kondo T, Abe O, Uchino J, Ogawa N (1980) Cooperative study of surgical adjuvant chemotherapy for colorectal carcinoma (second study): A preliminary report (in Japanese with English abstract). Gann to Kagakuryoho (Jpn J Cancer Chemother) 16:3399–3408
Inukai O (1980) Experimental studies on the problem of resection of primary tumor in large bowel carcinoma with liver metastasis (in Japanese with English abstract). Nagoya Igaku 103:164–175
Tabuchi Y, Nakae S, Nakamura T, Saitoh Y (1990) Prophylactic effects of intraportal administration of mitomycin C (MMC) and adriamycin (ADR) on experimental liver metastases. Bull Allied Med Sci (Kobe) 6:7–13
Isono T, Miyazaki M, Nakajima T, Okui K, Kondo Y (1990) Clinicopathological significance of intrahepatic metastases in hepatic metastatic carcinomas (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 91:1778–1783
Fisher ER, Turnbull RB (1985) The cytogenetic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet 100:102–108
Salsbury AJ, McKinna JA, Griffiths JD, Morgan CN (1965) Circulating cancer cells during excision of carcinomas of the rectum and colon with high ligation of the inferior mesenteric vein. Surg Gynecol Obstet 120:1266–1270
Honjo I, Mastumura H (1965) Vascular distribution of hepatic tumors: Experimental study. Rev Int Hepatol 15:681–690
Ohmura K, Ohtsuka S (1980) Relationship between histological findings and vascular architecture in the occurrence of metastatic carcinoma of the liver (in Japanese). Myakukann Gaku 20:793–803
Hill GJ, Larsen RR, Sas EM, Cohren BI, Irish TJ, Kandel E, Kogler J (1973) Cancer chemotherapy. II. Results for 603 courses of therapy in 400 consective patents followed for 18–52 months. Oncology 27:137–157
Hojo K, Kajitani T (1986) Adjuvant chemotherapy of colorectal cancer — results of prospectively randomized trials (in Japanese with English abstract). Gann to Kagakuryoho (Jpn J Cancer Chemother) 13:3056–3062
Metzger U, Mermillod B, Aeberhard P, Gloor F, Bissat A, Engel R, Laffer U, Martinoli S, Mueller W, Schroeder R, Weber W (1987) Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality. World J Surg 11:452–458
Loich JJ, Ahlgren JD, Cantrell J, Heim WJ, Wampler GL, Gullo JJ, Freyer JG, Alt DE (1991) A prospective randomized comparison of protracted infusion 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma: A mid-Atlantic oncology program study. Cancer 67:14–19
Polin AE, Kraut M, Baker L, Brodfuehrer J, Vaitkevicius V (1991) A dose-intensive regimen of 5-fluorouracil for the treatment of metastastic colorectal carcimona. Cancer 67:367–371
Freedman LS, Macaskill P, Smith AN (1984) Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 29:733–736
Walmark KN, Fisher B, Wieland HS, Henry RS, Lerner H, Legault-Poison S, Deckers P, Dimitrov N, Gordon PH, Jochimsen P, Oishi N (1984) The prognostic significance of preoperative cancinoembryonic antigen levels in colorectal cancer patients: Results of NSABP clinical trials. Ann Surg 199:375–382
Emidin SO, Stenling R, Roos G (1987) Prognostic value of DNA content in colorectal carcinoma. Cancer 60:1282–1287
Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y (1991) Colorectal cancer patients with high risk of hematogenous metastasis: Correlation with CEA levels in peripheral and draining venous blood during the period of operation. J Surg Oncol 47:87–91
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakane, M., Tabuchi, Y. & Saitoh, Y. Suppressive effect of doxorubicin on liver recurrence after resection of colonic VX2 cancer lesions: Difference in efficacy according to the injection protocol. Surg Today 23, 514–520 (1993). https://doi.org/10.1007/BF00730627
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00730627